港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

银诺医药-B

21.600

-0.500-2.26%

成交量：28.36万

成交额：610.13万

市值：98.71亿

市盈率：-51.89

高：22.800

开：22.140

低：20.800

收：22.100

52周最高：74.000

52周最低：20.800

股本：4.57亿

香港流通股本：4.20亿

量比：0.76

换手率：0.07%

股息：- -

股息率：- -

每股收益(LYR):-0.416

净资产收益率：-23.27%

总资产收益率：-11.61%

市净率：12.75

市盈率(LYR):-51.89

市销率: 154.15

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

港股异动 | 银诺医药-B(02591)盘中跌超5% 预期年度产生亏损约3.414亿元年内研发开支增加

银诺医药-B(02591)发盈警预期2025年产生亏损约3.414亿元

智通财经网

银诺医药-B预计全年亏损扩大研发投入激增1.03亿元

银诺医药-B（02591）：预计2025年度亏损扩大至约3.41亿元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02591"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02591","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02591\",,,,,undefined,":{"symbol":"02591","market":"HK","secType":"STK","nameCN":"银诺医药-B","latestPrice":21.6,"timestamp":1773994127289,"preClose":22.1,"halted":0,"volume":283600,"delay":0,"changeRate":-0.02262443438914027,"floatShares":420285370,"shares":457000000,"eps":-0.416279,"marketStatus":"休市中","change":-0.5,"latestTime":"03-20 16:08:47","open":22.14,"high":22.8,"low":20.8,"amount":6101272,"amplitude":0.090498,"askPrice":21.6,"askSize":5600,"bidPrice":20.86,"bidSize":400,"shortable":0,"etf":0,"ttmEps":-0.533,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774229400000},"marketStatusCode":7,"adr":0,"listingDate":1755187200000,"exchange":"SEHK","adjPreClose":22.1,"openAndCloseTimeList":[[1773970200000,1773979200000],[1773982800000,1773993600000]],"volumeRatio":0.7628167192986008,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02591\",,,,,undefined,":{"symbol":"02591","floatShares":420285370,"roa":"-11.61%","roe":"-23.27%","lyrEps":-0.416279,"volumeRatio":0.7628167192986008,"shares":457000000,"dividePrice":0,"high":22.8,"amplitude":0.090498,"preClose":22.1,"low":20.8,"week52Low":20.8,"pbRate":"12.75","psRate":"154.15","week52High":74,"institutionHeld":0,"latestPrice":21.6,"committee":-0.866667,"eps":-0.416279,"divideRate":0,"volume":283600,"delay":0,"ttmEps":-0.533,"open":22.14,"prevYearClose":30.64,"prevWeekClose":22.12,"prevMonthClose":27.8,"prevQuarterClose":30.64,"fiveDayClose":22.12,"twentyDayClose":27.7,"sixtyDayClose":30.94,"earningDate":1774195200000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02591\",params:#limit:5,,,undefined,":[{"date":"2026-03-23","symbol":"02591","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774229400000,"name":null,"time":"","dateTimestamp":1774195200000,"actualEps":null},{"date":"2025-08-29","symbol":"02591","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02591\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02591\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1770998400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02591\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02591","date":"2026-03-20","current":-40.525328,"percent":1,"low":-137.156472,"twenty":-78.964109,"median":-59.813644,"eighty":-50.865048,"high":-39.174717,"avg":-66.681602,"sd":20.442941,"marketCap":9867297938},"quantilePoints":[{"date":"2025-08-15","current":-137.156472,"twenty":-137.156472,"median":-137.156472,"eighty":-137.156472,"marketCap":26152907730},{"date":"2025-08-22","current":-127.373977,"twenty":-129.344203,"median":-127.373977,"eighty":-126.417438,"marketCap":24211425497},{"date":"2025-08-29","current":-106.390102,"twenty":-127.373977,"median":-126.095992,"eighty":-114.007182,"marketCap":20319324643},{"date":"2025-09-05","current":-78.151342,"twenty":-127.373977,"median":-117.586994,"eighty":-99.491273,"marketCap":18939730209},{"date":"2025-09-12","current":-83.843855,"twenty":-126.417438,"median":-105.433356,"eighty":-83.374192,"marketCap":20355870191},{"date":"2025-09-19","current":-79.271387,"twenty":-126.095992,"median":-93.890147,"eighty":-81.90749,"marketCap":19232094592},{"date":"2025-09-26","current":-78.986763,"twenty":-125.916102,"median":-85.498552,"eighty":-79.429082,"marketCap":19113321562},{"date":"2025-10-03","current":-76.5387,"twenty":-122.116665,"median":-83.843855,"eighty":-78.76383,"marketCap":18565138343},{"date":"2025-10-10","current":-69.068341,"twenty":-116.871032,"median":-83.374192,"eighty":-77.810518,"marketCap":16728724560},{"date":"2025-10-17","current":-67.838616,"twenty":-109.436934,"median":-79.738352,"eighty":-74.826182,"marketCap":16418087403},{"date":"2025-10-24","current":-59.813644,"twenty":-105.816054,"median":-79.429082,"eighty":-68.576451,"marketCap":14481173363},{"date":"2025-10-31","current":-57.61442,"twenty":-103.460611,"median":-78.986763,"eighty":-66.346017,"marketCap":13969535692},{"date":"2025-11-07","current":-56.556997,"twenty":-100.097405,"median":-78.243448,"eighty":-63.14919,"marketCap":13704580470},{"date":"2025-11-14","current":-61.96171,"twenty":-95.010372,"median":-77.299283,"eighty":-61.326336,"marketCap":15056765743},{"date":"2025-11-21","current":-54.467459,"twenty":-87.179427,"median":-75.823033,"eighty":-60.1184,"marketCap":13229488347},{"date":"2025-11-28","current":-82.342484,"twenty":-85.508442,"median":-76.5387,"eighty":-60.703449,"marketCap":20072642195},{"date":"2025-12-05","current":-82.313405,"twenty":-85.248884,"median":-75.823033,"eighty":-61.326336,"marketCap":20100051356},{"date":"2025-12-12","current":-63.824496,"twenty":-84.462171,"median":-74.404407,"eighty":-61.326336,"marketCap":15614085348},{"date":"2025-12-19","current":-62.072323,"twenty":-83.725798,"median":-74.049705,"eighty":-60.286674,"marketCap":15221220708},{"date":"2025-12-24","current":-59.762449,"twenty":-83.548712,"median":-73.276127,"eighty":-59.816947,"marketCap":14700446650},{"date":"2026-01-02","current":-56.27243,"twenty":-83.409096,"median":-71.366231,"eighty":-59.572219,"marketCap":13896444596},{"date":"2026-01-09","current":-57.1291,"twenty":-82.548826,"median":-69.803372,"eighty":-58.239982,"marketCap":14143127045},{"date":"2026-01-16","current":-56.980838,"twenty":-82.319221,"median":-67.499105,"eighty":-57.682607,"marketCap":14152263432},{"date":"2026-01-23","current":-58.213825,"twenty":-82.096799,"median":-66.291021,"eighty":-57.601428,"marketCap":14444627815},{"date":"2026-01-30","current":-54.613459,"twenty":-81.934522,"median":-64.906051,"eighty":-57.510573,"marketCap":13613216600},{"date":"2026-02-06","current":-49.064319,"twenty":-80.235292,"median":-63.834,"eighty":-57.242442,"marketCap":12261031327},{"date":"2026-02-13","current":-50.165477,"twenty":-79.691019,"median":-62.941647,"eighty":-57.039695,"marketCap":12608214032},{"date":"2026-02-20","current":-50.419859,"twenty":-79.623791,"median":-62.643943,"eighty":-56.891323,"marketCap":12653895967},{"date":"2026-02-27","current":-50.052949,"twenty":-79.470699,"median":-62.017016,"eighty":-56.651056,"marketCap":12699577902},{"date":"2026-03-06","current":-43.88908,"twenty":-79.397543,"median":-60.902753,"eighty":-56.29247,"marketCap":11045891858},{"date":"2026-03-13","current":-39.965904,"twenty":-79.214462,"median":-60.292057,"eighty":-54.71959,"marketCap":10104843999},{"date":"2026-03-20","current":-39.174717,"twenty":-78.964109,"median":-59.813644,"eighty":-50.865048,"marketCap":9867297938}],"updateTime":1774095778248},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02591\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2620201133","title":"港股异动 | 银诺医药-B(02591)盘中跌超5% 预期年度产生亏损约3.414亿元 年内研发开支增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2620201133","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620201133?lang=zh_cn&edition=fundamental","pubTime":"2026-03-20 11:48","pubTimestamp":1773978490,"startTime":"0","endTime":"0","summary":"消息面上，3月18日，银诺医药-B发布公告，尽管用于治疗2型糖尿病的依苏帕格鲁肽α于中国及澳门商业化上市后，集团于2025年度取得收益约人民币1.315亿元，集团预期本年度将取得亏损约人民币3.414亿元，而截至2024年12月31日止年度则取得亏损约人民币1.747亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416415.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK4588","VXUS","02591","BK4585"],"gpt_icon":0},{"id":"2620970235","title":"银诺医药-B(02591)发盈警 预期2025年产生亏损约3.414亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2620970235","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620970235?lang=zh_cn&edition=fundamental","pubTime":"2026-03-18 16:37","pubTimestamp":1773823033,"startTime":"0","endTime":"0","summary":"智通财经APP讯，银诺医药-B 公布，尽管用于治疗2型糖尿病的依苏帕格鲁肽α于中国及澳门商业化上市后，集团于2025年度取得收益约人民币1.315亿元，集团预期本年度将取得亏损约人民币3.414亿元，而截至2024年12月31日止年度则取得亏损约人民币1.747亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415397.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"银诺医药-B(02591)发盈警 预期2025年产生亏损约3.414亿元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1161","02591"],"gpt_icon":0},{"id":"1197852552","title":"银诺医药-B预计全年亏损扩大 研发投入激增1.03亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1197852552","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197852552?lang=zh_cn&edition=fundamental","pubTime":"2026-03-18 16:37","pubTimestamp":1773823032,"startTime":"0","endTime":"0","summary":"广州银诺医药集团股份有限公司近日发布盈利预警公告，预计2023财年将录得显著亏损。公司指出，亏损主要源于研发费用的大幅增加，期内研发支出同比激增约1.03亿元人民币，同时销售及分销成本也有所上升。此次研发费用的大幅增长，反映了银诺医药在创新药管线上的持续投入。银诺医药-B的股价表现将在一定程度上取决于其核心产品能否取得突破性进展，以及公司现金储备能否支撑其研发计划至关键节点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02591"],"gpt_icon":0},{"id":"1178999501","title":"银诺医药-B（02591）：预计2025年度亏损扩大至约3.41亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1178999501","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178999501?lang=zh_cn&edition=fundamental","pubTime":"2026-03-18 16:36","pubTimestamp":1773822994,"startTime":"0","endTime":"0","summary":"银诺医药-B3月18日晚间发布盈利预警称，预计2025年度将录得归属于母公司所有者的亏损约3.41亿元，而上年同期亏损约1.75亿元。期内，公司实现收入约1.32亿元，主要来自核心产品依苏帕格鲁肽α在中国及澳门上市后的商业化销售，上年同期收入为零。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"gpt_icon":0}],"pageSize":4,"totalPage":28,"pageCount":1,"totalSize":112,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02591\",params:#limit:6,delay:false,,,undefined,":[]}}